NasdaqGS:ZYMEBiotechs
Zymeworks (ZYME) Is Up 12.3% After Board Shakeup, Insider Investment, and Return to Profitability – Has The Bull Case Changed?
In August 2025, Zymeworks Inc. announced two new appointments to its Board of Directors, completed a private placement of 415,000 shares with board member Gregory A. Ciongoli, and reported a return to profitability in the second quarter with US$2.32 million in net income.
This combination of leadership changes, direct board member investment, and a reversal from losses the prior year points to renewed confidence and a potentially stronger financial foundation for the company.
Next, we'll...